JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2020, 69(2):67-74 | DOI: 10.36290/csf.2020.011

Evaluation of adherence to treatment in patients suffering from diabetes mellitus

Lucia Masaryková*, Tomáš Tesař, Ľubica Lehocká, Klaudia Bernáthová
Department of Organisation and Management of Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, SR

Background: Diabetes mellitus type 2 (DM) is a disease which is becoming pandemic these days. A successful treatment of chronic diabetes mellitus depends on early diagnosis and proper treatment. Just as the role of the doctor in treating the disease is important, so the community pharmacist plays an important role in taking the initiative in motivating patients to adhere to individual treatment regimes.

Objective: The main aim of the study was to analyze and assess patient adherence to pharmacological or non-pharmacological treatment, including the influence of the community pharmacist on that.

Method: All necessary data for the assessment were collected by anonymous questionnaire survey methods conducted within 7 months, as well as by personal consulting among pharmacists and patients. The results were assessed according to patients' gender and age.

Results: 117 respondents got involved in the survey, with 67 (57%) females and 50 (43%) males. The majority were aged 60-74 (48%), 84% suffered from diabetes mellitus type 2. Adherence to non-pharmacological treatment (regime and dietary measures) was 96% in females and 76% in males according to gender, and over 80% in each age category. Adherence to pharmacological treatment was up to 83% in females and 79% in males. According to age, over 70% adhered to pharmacological treatment all the time in each age category (except for 75+), with up to 88% aged 60-74.

Conclusion: According to the outcomes, we can observe that in our selected sample of patients the majority followed pharmacological or non-pharmacological treatment. The pharmacist also plays an important role in improving adherence to treatment. By providing patients with their expertise and professional knowledge while drug dispensing or individual conselling, the pharmacist can motivate the patient to follow not only pharmacological but also non-pharmacological treatment and thereby increase patient adherence itself to treatment.

Keywords: diabetes; treatment; community pharmacist; self-monitoring

Received: December 4, 2019; Accepted: March 19, 2020; Published: February 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Masaryková L, Tesař T, Lehocká Ľ, Bernáthová K. Evaluation of adherence to treatment in patients suffering from diabetes mellitus. Čes. slov. farm. 2020;69(2):67-74. doi: 10.36290/csf.2020.011.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. IDF Diabetes Atlas, 8th ed. International Diabetes Federation 2017. Available at: www.idf.org [cit. 2019-10-10].
    2. Quann E. E., et al. Consuming the daily recommended amounts of dairy products would reduce the prevalence of inadequate micronutrient intakes in the United States: diet modelling study based on NHANES 2007-2010. Nutrition Journal 2015; 14(1), 1-11. Go to original source... Go to PubMed...
    3. Activity at the diabetologists in the Slovak Republic 2017. National Health Information Center 2016. Available at: http://www.nczisk.sk/Documents/publikacie/2016/zs1711.pdf [cit. 2019-10-07].
    4. Šmahelová A., Lášticová M. Diabetology for pharmacy students. Praha: Mladá fronta 2011.
    5. Choe H. M., et al. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. American Journal of Managed Care 2005; 11(4), 253-260.
    6. Doucette W. R., et al. Community pharmacist-provided extended diabetes care. Annals of Pharmacotherapy 2009; 43(5), 882-889. Go to original source... Go to PubMed...
    7. Jaber L.A., et al. Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy 1996; 30(3), 238-243. Go to original source... Go to PubMed...
    8. Jameson J., Baty P. Pharmacist collaboration management of poorly controlled diabetes mellitus: a randomized controlled trial. The American Journal of Managed Care 2010; 16(4), 250-255.
    9. Odegard P. S., et al. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Annals of Pharmacotherapy 2005; 29(3), 433-430. Go to original source... Go to PubMed...
    10. Rothman R. L. et al. A randomized trial of a primary carebased disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. American Journal of Medicine 2005; 118(3), 276-284. Go to original source... Go to PubMed...
    11. Clifford R. M., et al. A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic. International Journal of Pharmacy Practice 2002; 10(2), 85-89. Go to original source...
    12. Clifford R. M., et al. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: The Fremantle Diabetes Study. Diabetes Care 2005; 28(4), 771-776. Go to original source... Go to PubMed...
    13. Krass I., et al. The pharmacy diabetes care program: assessment of a community pharmacy diabetes service model in Australia. Diabetic Medicine 2007; 24(6), 677-683. Go to original source... Go to PubMed...
    14. Sarkadi A., Rosenqvist U. Experience-based group education in type 2 diabetes: a randomised controlled trial. Patient Education and Counseling 2004; 53(3), 291-298. Go to original source... Go to PubMed...
    15. Phumipamorn S., et al. Effects of the pharmacist's input on glycaemic control and cardiovascular risks in Muslim diabetes. Primary Care Diabetes 2008; 2(1), 31-37. Go to original source... Go to PubMed...
    16. Suppapitiporn S., et al. Effect of diabetes drug counselling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial. Journal of the Medical Association of Thailand 2005; 88(4), S134-141.
    17. Fornos J. A., et al. A pharmacotherapy follow-up program in patients with type 2 diabetes in community pharmacies in Spain. Pharmacy World & Science 2006; 28(2), 65-72. Go to original source... Go to PubMed...
    18. Al Mazroui N. R., et al. Influence of pharmaceutical care on health outcomes in patients with type 2 diabetes mellitus. British Journal of Clinical Pharmacology 2009; 67(5), 547-557. Go to original source... Go to PubMed...
    19. Collins C., et al. Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Research and Clinical Practice 2011; 92, 145-152. Go to original source... Go to PubMed...
    20. Twigg G., et al. Pharmacist-managed diabetes center interventions ensure quality and safety in elderly patients. Consultant Pharmacist 2017; 32(5), 299-310. Go to original source... Go to PubMed...
    21. Krass I., et al. Development and validation of the Attitudes to Pharmacist Services for Diabetes Scale (APSDS). Research in Social and Administrative Pharmacy 2015; 11(1), 74-84. Go to original source... Go to PubMed...
    22. Doničová V. Health outcomes of treatment in patients with DM Type 2 nowadays in Slovakia and their other possibilities of improving. Medical letters: professional supplement in Health Newspaper 2015; 16, 18-19.
    23. Tinelli M., et al. Patients' preferences for an increased pharmacist role in the management of drug therapy. International Journal of Clinical Pharmacy 2013; 35(6), 1113-1119.
    24. Mitchell B. et al. Diabetes Medication Assistance Service: The pharmacist's role in supporting patient self-management of type 2 diabetes (T2DM) in Australia. Patient Education and Counselling 2011; 83(3), 288-294. Go to original source... Go to PubMed...
    25. Gajdošík J., Dukát A. Does patient non-adherence to diabetes mellitus type 2 treatment have any clinical and economical impact? Current clinical practice 2014; 2, 13-17.

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.